Insulin administration enhances growth of the β-cell mass in streptozotocin-treated newborn rats

Diabetes

Volumn 46, Issue 9, 1997, Pages 1445-1452

  Movassat, Jamileh ^a   Saulnier, Catherine ^a   Portha, Bernard ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRAL INSULIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030749043     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1445     Document Type: Article

References (42)

1. Swenne I: Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 35:193-201, 1992
2. Bonner-Weir S, Smith FE: Islet cell growth and the growth factors involved. Trends Endocrinol Metab 5:60-64, 1994
3. Portha B, Levacher C, Picon L, Rosselin G: Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23:889-895, 1974
4. Portha B, Blondel O, Serradas P, Mc Evoy R, Giroix MH, Kergoat M, Bailbé D: The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabete Metab 15:161-175, 1989
5. Bonner-Weir S, Trent DF, Honey RN, Weir GC: Responses of neonatal rat islets to streptozotocin. Diabetes 30:64-69, 1981
6. Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC: Limited β-cell regeneration in a β-cell deficient rat model: studies with dexamethasone. Metabolism 30:914-918, 1981
7. Cantenys D, Portha B, Dutrillaux MC, Hollande E, Roze C, Picon L: Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin. Virchows Arch B Cell Pathol 35:109-122, 1981
8. Wang RN, Bouwens L, Klöppel G: Beta-cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia 37:1088-1096, 1994
9. Weir GC, Leahy JL, Bonner-Weir S: Experimental reduction of the β-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab Rev 2:125-161, 1986
10. Dutrillaux MC, Portha B, Rozé C, Hollande E: Ultrastructural study of pancreatic β-cell regeneration in newborn rats after destruction by streptozotocin. Virchows Arch B Cell Pathol 39:173-185, 1982
11. Portha B, Picon L: Insulin treatment improves the spontaneous remission of neonatal streptozotocin diabetes in the rat. Diabetes 31:165-169, 1982
12. Michel C, Chariot J, Souchard M, Roze C: Modifications of the endocrine pancreas in rats after ethionine destruction of acini. Cell Mol Biol 28:135-148, 1982
13. Montana E, Bonner-Weir S, Weir GC: Transplanted beta cell response to increased metabolic demand: changes in beta cell replication and mass. J Clin Invest 93:1577-1582, 1994
14. McEvoy RC, Madson KL: Pancreatic insulin, glucagon and somatostatin-positive islet cell populations during the perinatal development of the rat: morphometric quantitation. Biol Neonate 38:248-254, 1980
15. McEvoy RC: Changes in the volumes of the A, B and D-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 30:813-817, 1981
16. Rutter WJ: The development of the endocrine and exocrine pancreas. In The Pancreas. Fitzgerald PJ, Morrison AB, Eds. Baltimore, MD, Williams and Wilkins, 1980, p. 30-38
17. Hellerström C: The life story of the pancreatic β-cell. Diabetologia 26:393-400, 1984
18. Dubois PM: Ontogeny of the endocrine pancreas. Horm Res 32:53-60, 1990
19. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256, 1995
20. Alpert S, Hanahan D, Teitelman G: Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53:295-308, 1988
21. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, Vassalli JD: Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene. Development 113:1257-1265, 1991
22. Teitelman G, Alpert S, Polak JM, Martinez A, Hanahan D: Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Development 118:1031-1039, 1993
23. Larsson LI, Hougaard DM: Coexpression of islet hormones and messenger RNAs in the human foetal pancreas. Endocrine 2:759-765, 1994
24. Gu D, Lee MS, Hrahl T, Sarvetnick N: Transitional cells in the regenerating pancreas. Development 120:1873-1881, 1994
25. Ferrand N, Astesano A, Phan HH, Lelong C, Rosselin G: Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated new-born rats. Am J Physiol 239:C1250-C1264, 1995
26. Wang RN, Bouwens L, Klöppel G: Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 39:548-557, 1996
27. King DL, Kitchen KC, Chick WL: Pancreatic β-cell replication: relation to insulin secretion. Endocrinology 103:1321-1327, 1978
28. McEvoy RC: Fetal rat pancreas in organ culture: effect of exogenous insulin on the development of islet cells. Horm Metab Res 13:5-8, 1981
29. Rabinovitch A, Quigley C, Russel T, Patel Y, Mintz DH: Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet β-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 31:160-164, 1982
30. Kalliecharan R, Gibson MA: Histogenesis of the islets of Langerhans in insulin-treated chick embryos. Can J Zool 50:265-277, 1972
31. Logothetopoulos J: Islet cell regeneration and neogenesis. In Handbook of Physiology. Vol. 1. Steiner DF, Freinkel N, Eds. Washington, DC, American Physiological Society, 1972, p. 67-76
32. Bonner-Weir S, Deery D, Leahy JL, Weir GC: Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53, 1989
33. McEvoy RC, Hegre OD: Syngeneic transplantation of fetal rat pancreas. II. Effect of insulin treatment on the growth and differentiation of pancreatic implants fifteen days after transplantation. Diabetes 27:988-995, 1978
34. McEvoy RC, Hegre OD: Syngeneic transplantation of fetal rat pancreas. III. Effect of insulin treatment on the growth and differentiation of the pancreatic implants after reversal of diabetes. Diabetes 28:141-146, 1979
35. Brown J, Heininger D, Kuret J, Mullen Y: Islet cells growth after transplantation of fetal pancreas and control of diabetes. Diabetes 30:9-13, 1981
36. Andersson A: The influence of hyperglycaemia, hyperinsulinaemia and genetic background on the fate of intrasplenically implanted islets. Diabetologia 25:269-272, 1983
37. Robertson RP, Olson LK, Zhang H-J: Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43:1085-1089, 1994
38. Genuth S, Martin P: Control of hyperglycemia in adult diabetics by pulsed insulin delivery. Diabetes 26:571-581, 1977
39. Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A: Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Diabetologia 14:223-227, 1978
40. Madsbad S, Krarup T, Regeur L, Faber OK, Binder C: Effect of strict blood glucose control on residual β-cell function in insulin-dependent diabetics. Diabetologia 20:530-534, 1981
41. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341:927-928, 1993
42. Rodriguez-Villar C, Conget I, Gonzalez-Clemente JM, Vidai J, Navarro P, Casamitjana R, Gomis R: Effect of insulin administration on β-cell function in subjects at high risk for type 1 diabetes mellitus. Metabolism 45:873-875, 1996